Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors (2020)
- Authors:
- Autor USP: MUSSI, MARISA MARCIA - FMRP
- Unidade: FMRP
- DOI: 10.1371/journal.pone.0242405
- Subjects: TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE; FARMACOTERAPIA; PEDIATRIA; HIV; CRIANÇAS
- Keywords: Antiretroviral therapy; Protease inhibitor therapy; Drug therapy; Protease inhibitors; Pediatrics; Reverse transcriptase inhibitors; Questionnaires; Drug adherence
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2020
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
YIN, Dwight E. et al. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, v. 15, n. 11, p. 1-18, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0242405. Acesso em: 04 ago. 2025. -
APA
Yin, D. E., Ludema, C., Cole, S. R., Golin, C. E., Miller, W. C., Warshaw, M. G., et al. (2020). Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, 15( 11), 1-18. doi:10.1371/journal.pone.0242405 -
NLM
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2025 ago. 04 ] Available from: https://doi.org/10.1371/journal.pone.0242405 -
Vancouver
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2025 ago. 04 ] Available from: https://doi.org/10.1371/journal.pone.0242405 - Imunização com a vacina pneumocócica durante a gestação em mulheres infectadas pelo HIV: resposta vacinal, transferência de anticorpos específicos e cinética de anticorpos nos primeiros seis meses de vida
- Infecção pelo vírus da imunodeficiência humana (HIV) na infância
- Congenital and perinatal cytomegalovirus infection
- Quality assurance program for peripheral blood mononuclear cell cryopreservation
- Lopinavir/ritonavir dosing during pregnancy in Brazil and maternal/infant laboratory abnormalities
- Clinical course of children with invasive pneumococcal disease (IPD) according to pneumococcal resistance to penicillin
- Missed opportunities for prevention of mother-to-child transmission of HIV-1 in the NISDI perinatal and LILAC cohorts
- Three postpartum antiretroviral regimens to prevent intrapartum HIV infection
- Birth prevalaence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil
- Detecção qualitativa e quantitativa de partículas virais e anticorpos contra o vírus da Hepatite B (VHB) no sangue e leite de nutrizes AGHBS/Anti-HBc e anti-HBs/anti-HBc positivas
Informações sobre o DOI: 10.1371/journal.pone.0242405 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003048359.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
